Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022

BUY
$8.42 - $15.32 $842 - $1,532
100 Added 66.67%
250 $2,000
Q3 2021

Oct 12, 2021

BUY
$15.75 - $30.29 $2,362 - $4,543
150 New
150 $4,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $82.1M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Piscataqua Savings Bank Portfolio

Follow Piscataqua Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piscataqua Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Piscataqua Savings Bank with notifications on news.